CCF642 was the first PDIA1 inhibitor constructed in the lab, which leads to irreversible lethal ER stress with subsequent MM cell apoptosis in in vitro and in vivo preclinical studies of bortezomib-resistant MM cells, without toxic effects on the healthy bone marrow hematopoietic cells [287]. The gene discussed is P4HB; the disease is Miyoshi myopathy.